Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Current Neurology and Neuroscience Reports|May 10, 2007
Environmental risk factors for brain tumorsJennifer M Connelly, Mark G MalkinJournal of Neuro-Oncology|August 28, 2010
Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomasBenjamin M Ellingson, Mark G Malkin, Scott D Rand, et al.Journal of Magnetic Resonance Imaging : JMRI|February 27, 2010
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularityBenjamin M Ellingson, Mark G Malkin, Scott D Rand, et al.Magnetic Resonance in Medicine|March 18, 2011
Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRIBenjamin M Ellingson, Peter S LaViolette, Scott D Rand, et al.Frontiers in Cell and Developmental Biology|June 20, 2022
tRNA Function and Dysregulation in CancerTania Gupta, Mark G Malkin, Suyun HuangThe Clinical Neuropsychologist|March 22, 2016
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Review and Neuropsychological Case StudyAshlee R Loughan, Aislyn Allen, Robert Perna, et al.Cureus|August 28, 2024
Treatment of Extraneural Metastases of Myxopapillary Ependymomas With Dose-Dense Temozolomide and LapatinibDevon C Riegel, Ekokobe Fonkem, Jennifer M ConnellyPhysiological Genomics|May 8, 2014
Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomicsMaxime S Heroux, Marla A Chesnik, Brian D Halligan, et al.Cancer|August 12, 2004
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinomaRose Lai, Chau T Dang, Mark G Malkin, et al.Neuro-Oncology|July 29, 2004
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapyJeffrey J Raizer, Mark G Malkin, Martin Kleber, et al.Pageof 5